Battelle, AmplifyBio, Andelyn team up NIH contract targeting stroke, neurological disease

(January 10, 2023) | By Carrie Ghose – Staff reporter.

A team comprising Battelle and two Central Ohio biotech startups has won a federal contract to supply the critical scientific and manufacturing support to bring regenerative medicine therapies for neurological disorders to market.

Battelle spinoff AmplifyBio, a contract research organization, and biotech manufacturer Andelyn Biosciences Inc. join the Columbus research giant as one of just three teams that can bid on individual jobs within an eight-year, up to $149 million program of the National Institutes of Health.